Federal Register / Vol. 75, No. 177 / Tuesday, September 14, 2010 / Notices 55827 

Sec. 36, N1⁄2 and SE1⁄4. 

The areas described aggregate 3,745 acres, 

more or less in San Bernardino County. 

The purpose of the proposed 

withdrawal is to protect and preserved 

the status quo of the lands pending 

action on an application for withdrawal 

for military purposes under the Engle 

Act. Currently, the lands are not being 

used for military training purposes. 

The use of a right-of-way or 

cooperative agreement would not 

prohibit new mineral location. 

The proposed withdrawal would not 

require water. 

There are no suitable alternative sites. 

The USMC analyzed lands elsewhere in 

the United States and concluded that 

the lands located adjacent to MCAGCC 

were the best site for the proposed 

training. 

On or before December 13, 2010, all 

persons who wish to submit comments, 

suggestions, or objections in connection 

with the proposed withdrawal may 

present their views in writing to the 

BLM, Barstow Field Office Manager at 

the address indicated above. 

Comments, including names and 

street addresses of respondents, will be 

available for public review at the BLM 

Barstow Field Office at the address 

above during regular business hours. 

Individual respondents may request 

confidentiality. Before including your 

address, phone number, e-mail address, 

or other personal identifying 

information in your comment, be 

advised that your entire comment— 

including your personal identifying 

information—may be made publicly 

available at any time. While you can ask 

us in your comment to withhold from 

public review your personal identifying 

information, we cannot guarantee that 

we will be able to do so. 

Notice is hereby given that a public 

meeting will be afforded in connection 

with the proposed withdrawal. A notice 

of the time and place of the public 

meeting will be published in the 

Federal Register and a local newspaper 

at least 30 days before the scheduled 

date of the meeting. 

This withdrawal proposal will be 

processed in accordance with the 

regulations set forth in 43 CFR Part 

2300. 

For a period of 2 years from the date 

of publication of this notice in the 

Federal Register, the lands will be 

segregated from settlement, sale, 

location and entry under the public land 

laws, including the United States 

mining laws, and from the operation of 

the mineral and geothermal leasing laws 

and the Materials Act of 1947 unless the 

application is denied or canceled or the 

withdrawal is approved prior to that 

date. 

Licenses, permits, cooperative 

agreement, or discretionary land use 

authorizations of a temporary nature 

which will not significantly impact the 

values to be protected by the 

withdrawal may be allowed with the 

approval of the authorized officer of 

BLM during the segregative period. 

Authority: 43 CFR 2310.3–1(a), (b)(1) and 

(2). 

Karla D. Norris, 

Associate Deputy State Director, CA–930. 

[FR Doc. 2010–22817 Filed 9–13–10; 8:45 am] 

BILLING CODE 3810–FF–P 

INTERNATIONAL TRADE 

COMMISSION 

[USITC SE–10–027] 

Government in the Sunshine Act 

Meeting Notice 

AGENCY HOLDING THE MEETING: United 

States International Trade Commission. 

TIME AND DATE: September 20, 2010 at 

1 p.m. 

PLACE: Room 101, 500 E Street, SW., 

Washington, DC 20436, Telephone: 

(202) 205–2000. 

STATUS: Open to the public. 

MATTERS TO BE CONSIDERED: 

1. Agenda for future meetings: none. 

2. Minutes. 

3. Ratification List. 

4. Inv. No. 731–TA–125 (Third 

Review) (Potassium Permanganate from 

China)—briefing and vote. (The 

Commission is currently scheduled to 

transmit its determination and 

Commissioners’ opinions to the 

Secretary of Commerce on or before 

September 30, 2010.) 

5. Inv. Nos. 731–TA–1082 and 1083 

(Review)(Chlorinated Isocyanurates 

from China and Spain)—briefing and 

vote. (The Commission is currently 

scheduled to transmit its determinations 

and Commissioners’ opinions to the 

Secretary of Commerce on or before 

September 30, 2010.) 

6. Outstanding action jackets: none. 

In accordance with Commission 

policy, subject matter listed above, not 

disposed of at the scheduled meeting, 

may be carried over to the agenda of the 

following meeting. 

By order of the Commission. 

Issued: September 10, 2010. 

William R. Bishop, 

Hearings and Meetings Coordinator. 

[FR Doc. 2010–23055 Filed 9–10–10; 4:15 pm] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1103–0016] 

Justice Management Division; Agency 

Information Collection Activities: 

Proposed Collection; Comments 

Requested 

ACTION: 30-Day Notice of Information 

Collection Under Review: Certification 

of Identity. 

The Department of Justice (DOJ), 

Justice Management Division, Facilities 

and Administrative Services Staff (JMD/ 

FASS) will be submitting the following 

information collection request to the 

Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. The proposed 

information collection is published to 

obtain comments from the public and 

affected agencies. This proposed 

information collection was previously 

published in the Federal Register 

Volume 75, Number 133 page 39972 on 

July 13, 2010, allowing for a 60 day 

comment period. 

The purpose of this notice is to allow 

for an additional 30 days for public 

comment until October 14, 2010. This 

process is conducted in accordance with 

5 CFR 1320.10. 

Written comments and/or suggestions 

regarding the items contained in this 

notice, especially the estimated public 

burden and associated response time, 

should be directed to The Office of 

Management and Budget, Office of 

Information and Regulatory Affairs, 

Attention Department of Justice Desk 

Officer, Washington, DC 20503. 

Additionally, comments may be 

submitted to OMB via facsimile to 

(202)–395–5806. 

Written comments and suggestions 

from the public and affected agencies 

concerning the proposed collection of 

information are encouraged. Your 

comments should address one or more 

of the following four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

—Evaluate the accuracy of the agencies 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

—Minimize the burden of the collection 

of information on those who are to 


jlentini on DSKJ8SOYB1PROD with NOTICES
55828 Federal Register / Vol. 75, No. 177 / Tuesday, September 14, 2010 / Notices 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Overview of This Information 

Collection 

(1) Type of Information Collection: 

Extension of a Currently Approved 

Collection. 

(2) Title of the Form/Collection: 

Certification of Identity. 

(3) Agency form number, if any, and 

the applicable component of the 

Department of Justice sponsoring the 

collection: Form DOJ–361. Facilities and 

Administrative Services Staff, Justice 

Management Division, U.S. Department 

of Justice. 

(4) Affected public who will be asked 

or required to respond, as well as a brief 

abstract: Primary: American Citizens. 

Other: Federal Government. The 

information collection will be used by 

the Department to identify individuals 

requesting certain records under the 

Privacy Act. Without this form an 

individual cannot obtain the 

information requested. 

(5) An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond: It is estimated that 27,000 

respondents will complete the form 

within approximately 30 minutes. 

(6) An estimate of the total burden (in 

hours) associated with the collection: 

There are an estimated 13,500 annual 

burden hours associated with this 

collection. 

If Additional Information is Required 

Contact: Lynn Murray, Department 

Clearance Officer, United States 

Department of Justice, Policy and 

Planning Staff, Justice Management 

Division, Suite 1600, Patrick Henry 

Building, 601 D Street, NW., 

Washington, DC 20530. 

Dated: September 8, 2010. 

Lynn Murray, 

Department Clearance Officer, PRA, United 

States Department of Justice. 

[FR Doc. 2010–22888 Filed 9–13–10; 8:45 am] 

BILLING CODE 4410–CW–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–318F] 

Controlled Substances: Final Revised 

Aggregate Production Quotas for 2010 

AGENCY: Drug Enforcement 

Administration (DEA), Justice. 

ACTION: Notice of final aggregate 

production quotas for 2010. 

SUMMARY: This notice establishes final 

2010 aggregate production quotas for 

controlled substances in schedules I and 

II of the Controlled Substances Act 

(CSA). DEA has taken into consideration 

comments received in response to a 

notice of the proposed revised aggregate 

production quotas for 2010 published 

June 23, 2010 (75 FR 35838). 

DATES: Effective Date: September 14, 

2010. 

FOR FURTHER INFORMATION CONTACT: 

Christine A. Sannerud, Ph.D., Chief, 

Drug and Chemical Evaluation Section, 

Drug Enforcement Administration, 8701 

Morrissette Drive, Springfield, VA 

22152, Telephone: (202) 307–7183. 

SUPPLEMENTARY INFORMATION: Section 

306 of the CSA (21 U.S.C. 826) requires 

that the Attorney General establish 

aggregate production quotas for each 

basic class of controlled substance listed 

in schedules I and II. This responsibility 

has been delegated to the Administrator 

of the DEA by 28 CFR 0.100. The 

Administrator, in turn, has redelegated 

this function to the Deputy 

Administrator, pursuant 28 CFR 0.104. 

The 2010 aggregate production quotas 

represent those quantities of controlled 

substances in schedules I and II that 

may be produced in the United States in 

2010 to provide adequate supplies of 

each substance for: The estimated 

medical, scientific, research and 

industrial needs of the United States; 

lawful export requirements; and the 

establishment and maintenance of 

reserve stocks (21 U.S.C. 826(a) and 21 

CFR 1303.11). These quotas do not 

include imports of controlled 

substances. 

On June 23, 2010, a notice of the 

proposed revised 2010 aggregate 

production quotas for certain controlled 

substances in schedules I and II was 

published in the Federal Register (75 

FR 35838). All interested persons were 

invited to comment on or object to these 

proposed aggregate production quotas 

on or before July 23, 2010. 

Fourteen companies, thirteen DEA 

registered manufacturers and one nonregistrant, commented on a total of 28 

schedules I and II controlled substances 

within the published comment period. 

Comments received proposed that the 

aggregate production quotas for 

alfentanil, amphetamine (for 

conversion), amphetamine (for sale), 

codeine (for conversion), codeine (for 

sale), dextropropoxyphene, 

dihydromorphine, diphenoxylate, 

gamma hydroxybutyric acid, 

hydrocodone, hydromorphone, 

lisdexamfetamine, meperidine, 

methadone, methylphenidate, morphine 

(for conversion), morphine (for sale), 

nabilone, opium (tincture), oxycodone 

(for conversion), oxycodone (for sale), 

oxymorphone (for sale), remifentanil, 

sufentanil, tapentadol, 

tetrahydrocannabinols, thebaine and 

tilidine were insufficient to provide for 

the estimated medical, scientific, 

research, and industrial needs of the 

United States, for export requirements 

and for the establishment and 

maintenance of reserve stocks. 

DEA has taken into consideration the 

above comments along with the relevant 

2009 year-end inventories, initial 2010 

manufacturing quotas, 2010 export 

requirements, actual and projected 2010 

sales, research, product development 

requirements and additional 

applications received. Based on this 

information, the DEA has adjusted the 

final 2010 aggregate production quotas 

for alfentanil, amphetamine (for 

conversion), amphetamine (for sale), 

carfentanil, dihydromorphine, 

diphenoxylate, marihuana, morphine 

(for sale), noroxymorphone (for sale), 

opium (tincture), oxycodone (for 

conversion), oxycodone (for sale), 

oxymorphone (for conversion), 

oxymorphone (for sale), tapentadol, 

tetrahydrocannabinols, and tilidine. 

4-anilino-N-phenethyl-4-piperidine 

(ANPP) pursuant to DEA’s final rule 

published in the Federal Register on 

June 29, 2010 (75 FR 37295) will be 

controlled as a schedule II controlled 

substance on August 30, 2010. As such, 

DEA has established an aggregate 

production quota for ANPP to meet the 

estimated medical, scientific, research, 

and industrial needs of the United 

States; lawful export requirements; and 

the establishment and maintenance of 

reserve stocks. 

Regarding codeine (for conversion), 

codeine (for sale), dextropropoxyphene, 

gamma hydroxybutyric acid, 

hydrocodone, hydromorphone, 

lisdexamfetamine, meperidine, 

methadone, methylphenidate, morphine 

(for conversion), nabilone, remifentanil, 

sufentanil, and thebaine, DEA has 

determined that the proposed revised 

2010 aggregate production quotas are 

sufficient to meet the current 2010 

estimated medical, scientific, research, 

and industrial needs of the United 

States and to provide for adequate 

inventories. 

Therefore, under the authority vested 

in the Attorney General by Section 306 

of the CSA (21 U.S.C. 826), and 

delegated to the Administrator of the 

DEA by 28 CFR 0.100, and redelegated 

to the Deputy Administrator, pursuant 

to 28 CFR 0.104, the Deputy 


jlentini on DSKJ8SOYB1PROD with NOTICES